idiopathic pulmonary arterial hypertension |
Disease ID | 820 |
---|---|
Disease | idiopathic pulmonary arterial hypertension |
Definition | Increased blood pressure in the arteries of the lungs; the etiology is unknown. |
Synonym | essential pulmonary hypertension hypertension primary pulmonary hypertension, pulmonary, primary idiopathic pulmonary hypertension ipah ppht - primary pulmonary hypertension prim pulm hypertension primary pulmonary hypertension primary pulmonary hypertension (disorder) pulmonary hypertension primary pulmonary hypertension, essential pulmonary hypertension, idiopathic pulmonary hypertension, primary pulmonary primary hypertension |
Orphanet | |
DOID | |
ICD10 | |
UMLS | C0152171 |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:27) C0009782 | connective tissue disease | 8 C1619734 | pulmonary arterial hypertension | 3 C0018799 | heart disease | 3 C0152021 | congenital heart disease | 3 C0009782 | connective tissue diseases | 2 C0013371 | shigella | 2 C0036421 | systemic sclerosis | 2 C0018801 | heart failure | 2 C0153500 | heart ca | 1 C0018799 | cardiac disorders | 1 C0011644 | scleroderma | 1 C0018802 | congestive heart failure | 1 C0020538 | hypertension | 1 C0600260 | obstructive pulmonary disease | 1 C0018799 | heart diseases | 1 C0028754 | obesity | 1 C0266526 | norrie disease | 1 C0002871 | anemia | 1 C0398623 | hypercoagulability | 1 C0024115 | pulmonary disease | 1 C0020542 | pulmonary hypertension | 1 C0024117 | chronic obstructive pulmonary disease | 1 C1527336 | sjogren's syndrome | 1 C0020550 | hyperthyroidism | 1 C0042373 | vascular disease | 1 C0040053 | thrombosis | 1 C1145670 | respiratory failure | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:61) 93 | ACVR2B | 2.527 | DISEASES 94 | ACVRL1 | 4.381 | DISEASES 501 | ALDH7A1 | 1.488 | DISEASES 240 | ALOX5 | 1.421 | DISEASES 241 | ALOX5AP | 1.204 | DISEASES 23365 | ARHGEF12 | 1.486 | DISEASES 23545 | ATP6V0A2 | 1.525 | DISEASES 650 | BMP2 | 2.456 | DISEASES 655 | BMP7 | 1.504 | DISEASES 659 | BMPR2 | 6.617 | DISEASES 796 | CALCA | 1.229 | DISEASES 978 | CDA | 1.09 | DISEASES 1059 | CENPB | 1.484 | DISEASES 1186 | CLCN7 | 1.492 | DISEASES 1558 | CYP2C8 | 1.17 | DISEASES 6993 | DYNLT1 | 1.563 | DISEASES 1889 | ECE1 | 1.188 | DISEASES 1906 | EDN1 | 4.227 | DISEASES 1910 | EDNRB | 1.603 | DISEASES 10938 | EHD1 | 1.221 | DISEASES 2022 | ENG | 1.091 | DISEASES 3266 | ERAS | 1.978 | DISEASES 5394 | EXOSC10 | 1.196 | DISEASES 2152 | F3 | 1.525 | DISEASES 2200 | FBN1 | 2.115 | DISEASES 2317 | FLNB | 1.489 | DISEASES 22862 | FNDC3A | 1.864 | DISEASES 2550 | GABBR1 | 1.789 | DISEASES 8200 | GDF5 | 1.362 | DISEASES 9402 | GRAP2 | 1.456 | DISEASES 8091 | HMGA2 | 1.326 | DISEASES 3150 | HMGN1 | 2.162 | DISEASES 3151 | HMGN2 | 2.45 | DISEASES 3212 | HOXB2 | 2.358 | DISEASES 3363 | HTR7 | 3.333 | DISEASES 3397 | ID1 | 1.775 | DISEASES 259307 | IL4I1 | 2.423 | DISEASES 1316 | KLF6 | 1.226 | DISEASES 3984 | LIMK1 | 1.364 | DISEASES 27030 | MLH3 | 1.829 | DISEASES 4311 | MME | 1.374 | DISEASES 4624 | MYH6 | 1.016 | DISEASES 4782 | NFIC | 1.282 | DISEASES 4878 | NPPA | 1.448 | DISEASES 4879 | NPPB | 1.108 | DISEASES 8654 | PDE5A | 2.849 | DISEASES 9124 | PDLIM1 | 1.351 | DISEASES 6152 | RPL24 | 1.24 | DISEASES 462 | SERPINC1 | 1.583 | DISEASES 6580 | SLC22A1 | 1.512 | DISEASES 6582 | SLC22A2 | 1.742 | DISEASES 9356 | SLC22A6 | 1.758 | DISEASES 9376 | SLC22A8 | 1.523 | DISEASES 4093 | SMAD9 | 3.074 | DISEASES 11005 | SPINK5 | 1.185 | DISEASES 7042 | TGFB2 | 1.239 | DISEASES 7048 | TGFBR2 | 1.945 | DISEASES 7056 | THBD | 2.5 | DISEASES 8718 | TNFRSF25 | 1.356 | DISEASES 7432 | VIP | 1.179 | DISEASES 23038 | WDTC1 | 1.018 | DISEASES |
Locus | (Waiting for update.) |
Disease ID | 820 |
---|---|
Disease | idiopathic pulmonary arterial hypertension |
Manually Symptom | UMLS | Name(Total Manually Symptoms:4) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:5) C0018801 | heart failure | 2 C0856169 | endothelial dysfunction | 1 C0344706 | right atrial appendage aneurysm | 1 C1839611 | n syndrome | 1 C0040038 | thromboembolism | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:20) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs10744676 | 20556823 | 3741 | KCNA5 | umls:C0152171 | BeFree | Our results provide the first evidence for an association between the KCNA5 rs10744676 variant and PAH associated with SSc. | 0.001900093 | 2010 | KCNA5 | 12 | 5043783 | C | T |
rs137852741 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202556360 | C | G,T |
rs137852741 | 21622843 | 659 | BMPR2 | umls:C0152171 | BeFree | Three BMPR2 mutants, D485G, N519K, and R899X, which are known to be involved in PAH, were chosen as our model system. | 0.15338735 | 2011 | BMPR2 | 2 | 202556360 | C | G,T |
rs137852742 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202464950 | C | G |
rs137852743 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202467625 | T | G |
rs137852744 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202530866 | G | A |
rs137852745 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202552756 | A | G |
rs137852745 | 21622843 | 659 | BMPR2 | umls:C0152171 | BeFree | Three BMPR2 mutants, D485G, N519K, and R899X, which are known to be involved in PAH, were chosen as our model system. | 0.15338735 | 2011 | BMPR2 | 2 | 202552756 | A | G |
rs137852746 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202552773 | C | T |
rs137852747 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202513807 | C | A |
rs137852748 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202556282 | C | T |
rs137852749 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202552774 | G | A |
rs137852750 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202467638 | T | A,C |
rs137852751 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202530820 | C | T |
rs137852752 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202556361 | G | A,C |
rs137852752 | 15965979 | 659 | BMPR2 | umls:C3203102 | UNIPROT | BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension. | 0.210314791 | 2005 | BMPR2 | 2 | 202556361 | G | A,C |
rs137852753 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202518831 | C | T |
rs344781 | 20967855 | 343170 | OR14K1 | umls:C0152171 | BeFree | In the Italian cohort, the rs344781 G allele was associated with SSc-related digital ulceration (odds ratio [OR] 1.39), pulmonary arterial hypertension (PAH) (OR 1.81), anticentromere antibody (ACA) positivity (OR 1.45), and limited cutaneous SSc (lcSSc) (OR 1.37). | 0.000271442 | 2011 | PLAUR | 19 | 43670636 | C | T |
rs483352902 | NA | 659 | BMPR2 | umls:C0152171 | CLINVAR | NA | 0.15338735 | NA | BMPR2 | 2 | 202377518 | C | - |
rs5743704 | 21905008 | 7097 | TLR2 | umls:C0152171 | BeFree | Among patients with SSc, the rare TLR2 Pro631His variant is robustly associated with antitopoisomerase positivity, the diffuse form of the disease, and the development of PAH. | 0.000271442 | 2012 | TLR2 | 4 | 153704799 | C | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:6) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001667 | Right ventricular hypertrophy | MP:0010420 | muscular ventricular septal defect | abnormal communications between the two lower chambers of the heart, involving the muscular septum and often occurring as multiple communications, and includes central muscular or midmuscular, apical, or marginal communications when the defect is along th |
HP:0001635 | Congestive heart failure | MP:0011925 | abnormal heart echocardiography feature | any anomaly in echocardiographic representation of systolic and diastolic function, ventricular compliance, valvular function, or interventricular septum features |
HP:0010741 | Edema of the lower limbs | MP:0009657 | failure of chorioallantoic fusion | failure to initiate and/or complete the formation of a highly vascularized extra-embryonic fetal membrane by fusion of the chorion and allantois |
HP:0002092 | Pulmonary hypertension | MP:0005258 | ocular hypertension | abnormal elevation of the intraocular pressure |
HP:0005317 | Increased pulmonary vascular resistance | MP:0010935 | increased airway resistance | greater opposition to flow of air caused by the forces of friction, measured as the ratio of driving pressure to the rate of air flow |
HP:0004870 | Chronic hemolytic anemia | MP:0001585 | hemolytic anemia | deficiency of red cells resulting from an increased rate of erythrocyte destruction |
Mapped by homologous gene(Total Items:15) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001279 | Syncope | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0002092 | Pulmonary hypertension | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001785 | Ankle swelling | MP:0014167 | ectopic bone | the appearance of an extra bone structure at an atypical location |
HP:0001635 | Congestive heart failure | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0002094 | Dyspnea | MP:0014185 | cerebellum atrophy | acquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal |
HP:0001667 | Right ventricular hypertrophy | MP:0013241 | embryo tissue necrosis | morphological changes resulting from pathological death of some or all embryo tissue; usually due to irreversible damage |
HP:0100749 | Chest pain | MP:0020154 | impaired humoral immune response | impaired response of the immune system that mediates secreted antibodies produced in B cells |
HP:0003549 | Abnormality of connective tissue | MP:0014179 | abnormal blood-retinal barrier function | anomaly in the function of the part of the blood-ocular barrier that consists of cells that are joined tightly together to prevent certain substances from entering the tissue of the retina; the BRB consists of non-fenestrated capillaries of the retinal ci |
HP:0005317 | Increased pulmonary vascular resistance | MP:0013401 | increased endometrial gland number | greater than normal numbers of the simple or branched tubular glands found in the mucus membrane of the uterus |
HP:0030148 | Heart murmur | MP:0014185 | cerebellum atrophy | acquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal |
HP:0004870 | Chronic hemolytic anemia | MP:0011178 | increased erythroblast number | greater number of the nucleated precursor of erythrocytes |
HP:0010741 | Edema of the lower limbs | MP:0013258 | abnormal extracellular matrix morphology | any structural anomaly of the structure lying external to one or more cells, which provides structural support for cells or tissues; in mammals, the extracellular matrix is completely external to the cell |
HP:0001962 | Palpitations | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0005180 | Tricuspid regurgitation | MP:0013241 | embryo tissue necrosis | morphological changes resulting from pathological death of some or all embryo tissue; usually due to irreversible damage |
HP:0002105 | Hemoptysis | MP:0011098 | embryonic lethality during organogenesis, complete penetrance | death of all organisms of a given genotype in a population between embryo turning and the completion of organogenesis (Mus: E9-9.5 to less than E14) |
Disease ID | 820 |
---|---|
Disease | idiopathic pulmonary arterial hypertension |
Case | (Waiting for update.) |